Association between tight junction proteins and cognitive performance in untreated persons with HIV
- PMID: 38704619
- PMCID: PMC11216391
- DOI: 10.1097/QAD.0000000000003923
Association between tight junction proteins and cognitive performance in untreated persons with HIV
Abstract
Background: HIV-associated neurocognitive disorders (HAND) still affects persons with HIV (PWH) and their pathogenesis is not completely understood. We aimed to explore the association between plasma and cerebrospinal fluid (CSF) markers of blood-brain barrier (BBB) impairment and HAND in untreated PWH.
Design: Cross-sectional study.
Methods: We enrolled untreated PWH, who underwent blood examinations and lumbar puncture to measure inflammation (IL-15, TNF-α), BBB damage (zonulin and tight junction proteins, tight junction proteins: occludin, claudin-5) and endothelial adhesion molecules (VCAM-1, ICAM-1). A comprehensive neurocognitive battery was used to diagnose HAND (Frascati criteria).
Results: Twenty-one patients (21/78, 26.9%) patients presented HAND (100% ANI). HAND patients displayed more frequently non-CNS AIDS-defining conditions, lower nadir CD4 + T cells and increased CD4 + T-cell exhaustion (lower CD4 + CD127 + and CD4 + CD45RA + T-cell percentages), in comparison to individuals without cognitive impairment. Furthermore, HAND was characterized by higher plasma inflammation (IL-15) but lower CSF levels of biomarkers of BBB impairment (zonulin and occludin). The association between BBB damage with HAND was confirmed by fitting a multivariable logistic regression. CSF/plasma endothelial adhesion molecules were not associated with HAND but with a poor performance in different cognitive domains.
Conclusion: By showing heightened inflammation and BBB impairment, our study suggests loss of BBB integrity as a possible factor contributing to the development of HAND in untreated PWH.
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
There are no conflicts of interest.
Figures



Similar articles
-
CSF Extracellular Vesicle Aβ42 and Tau/Aβ42 Ratio Are Associated with Cognitive Impairment in Older People with HIV.Viruses. 2023 Dec 31;16(1):72. doi: 10.3390/v16010072. Viruses. 2023. PMID: 38257772 Free PMC article.
-
CSF Inflammation Markers Associated with Asymptomatic Viral Escape in Cerebrospinal Fluid of HIV-Positive Individuals on Antiretroviral Therapy.Viruses. 2023 Aug 29;15(9):1829. doi: 10.3390/v15091829. Viruses. 2023. PMID: 37766236 Free PMC article.
-
Cerebrospinal fluid biomarkers of inflammation and immune activation associated with neurocognitive impairment among US Latinos with HIV.AIDS. 2025 Jun 1;39(7):838-847. doi: 10.1097/QAD.0000000000004143. Epub 2025 Feb 4. AIDS. 2025. PMID: 39912739
-
Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.J Neurovirol. 2019 Oct;25(5):702-709. doi: 10.1007/s13365-018-0695-4. Epub 2019 Jan 4. J Neurovirol. 2019. PMID: 30610738 Free PMC article. Review.
-
Disruption of blood-brain barrier: effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins.J Neurovirol. 2023 Dec;29(6):658-668. doi: 10.1007/s13365-023-01179-3. Epub 2023 Oct 29. J Neurovirol. 2023. PMID: 37899420 Review.
Cited by
-
Structural and Functional Dysregulation of the Brain Endothelium in HIV Infection and Substance Abuse.Cells. 2024 Aug 24;13(17):1415. doi: 10.3390/cells13171415. Cells. 2024. PMID: 39272987 Free PMC article. Review.
References
-
- Wang Y, Liu M, Lu Q, Farrell M, Lappin JM, Shi J, et al. . Global prevalence and burden of HIV-associated neurocognitive disorder: a meta-analysis . Neurology 2020; 95:e2610–e2621. - PubMed
-
- Nightingale S, Ances B, Cinque P, Dravid A, Dreyer AJ, Gisslén M, et al. . Cognitive impairment in people living with HIV: consensus recommendations for a new approach . Nat Rev Neurol 2023; 19:424–433. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous